celecoxib has been researched along with Appendiceal Neoplasms in 3 studies
Appendiceal Neoplasms: Tumors or cancer of the APPENDIX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Vierra, M | 1 |
| Dhiman, A | 1 |
| Witmer, HDD | 1 |
| Ulrich, L | 1 |
| Hindi, E | 1 |
| Fenton, E | 1 |
| Shergill, A | 1 |
| Polite, B | 1 |
| Eng, OS | 1 |
| Turaga, KK | 1 |
| Raghav, KP | 1 |
| Shetty, AV | 1 |
| Kazmi, SM | 1 |
| Zhang, N | 1 |
| Morris, J | 1 |
| Taggart, M | 1 |
| Fournier, K | 1 |
| Royal, R | 1 |
| Mansfield, P | 1 |
| Eng, C | 1 |
| Wolff, RA | 1 |
| Overman, MJ | 1 |
| Choudry, HA | 1 |
| Mavanur, A | 1 |
| O'Malley, ME | 1 |
| Zeh, HJ | 1 |
| Guo, Z | 1 |
| Bartlett, DL | 1 |
1 trial available for celecoxib and Appendiceal Neoplasms
| Article | Year |
|---|---|
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendiceal | 2013 |
2 other studies available for celecoxib and Appendiceal Neoplasms
| Article | Year |
|---|---|
Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal Dissemination.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; C | 2022 |
Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Appendiceal Neoplasms; Celecoxib; Colonic N | 2012 |